StockData
Nautilus Biotechnology, Inc. logo

Nautilus Biotechnology, Inc. (NAUT) stock

NAUTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 6/30
$2.36+0.26 (+12.38%)

Close on Nov 17, 2026Market cap $300.60MP/E –Yield –

Nautilus Biotechnology operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Nautilus Biotechnology's operating cash flow for the twelve months ending Sep 30, 2026 was -$52.48M. For fiscal 2025 it was -$50.70M. The highest annual figure on record is -$14.00M in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$50.70M–
FY2024Dec 31, 2024-$59.15M–
FY2023Dec 31, 2023-$51.71M–
FY2022Dec 31, 2022-$45.81M–
FY2021Dec 31, 2021-$39.24M–
FY2020Dec 31, 2020-$14.00M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$13.28M–
Q2 FY2026Jun 30, 2026-$13.73M–
Q1 FY2026Mar 31, 2026-$13.10M–
Q4 FY2025Dec 31, 2025-$12.38M–
Q3 FY2025Sep 30, 2025-$11.03M–
Q2 FY2025Jun 30, 2025-$13.35M–
Q1 FY2025Mar 31, 2025-$13.94M–
Q4 FY2024Dec 31, 2024-$14.31M–
Q3 FY2024Sep 30, 2024-$13.11M–
Q2 FY2024Jun 30, 2024-$15.46M–
Q1 FY2024Mar 31, 2024-$16.27M–
Q4 FY2023Dec 31, 2023-$13.90M–
Q3 FY2023Sep 30, 2023-$11.74M–
Q2 FY2023Jun 30, 2023-$13.55M–
Q1 FY2023Mar 31, 2023-$12.52M–
Q4 FY2022Dec 31, 2022-$10.38M–
Q3 FY2022Sep 30, 2022-$9.57M–
Q2 FY2022Jun 30, 2022-$13.53M–
Q1 FY2022Mar 31, 2022-$12.34M–
Q4 FY2021Dec 31, 2021-$10.52M–
Q3 FY2021Sep 30, 2021-$14.18M–
Q2 FY2021Jun 30, 2021-$8.29M–
Q1 FY2021Mar 31, 2021-$6.25M–
Q4 FY2020Dec 31, 2020-$4.73M–
Q3 FY2020Sep 30, 2020-$3.37M–
Q2 FY2020Jun 30, 2020$0–

More Nautilus Biotechnology figures

See a number that looks wrong?